SCN1A and epilepsy: After combining our in-house control and ExAc data in a meta-analysis, only the p.T1174S variant remained significantly enriched after correction for multiple testing (Table 1) in epilepsy patients supporting p.T1174S as the only identified SCN1A genetic risk factor for epilepsy in our cohort.